Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

The MarketWatch News Department was not involved in the creation of this content. AI in Biotechnology Market worth $22,716.5 million by 2035 with 18.5% CAGR | MarketsandMarkets(TM). DELRAY BEACH, Fla.

After taking a shot at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical ...

The "AI in Biotechnology Market - Global Industry Size, Share, Growth, Trends, Opportunity, and Forecast, 2025-2033" report has been added to ResearchAndMarkets.com's offering. The global AI in ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Biotech firms use AI in trials to target patients more ...

To support tenants using AI, life sciences buildings need increased slab loads, electricity and water, all expensive upgrades for owners.

Isomorphic says its AI drug design engine has foundational AI models capable of working across multiple therapeutic areas and drug modalities. The company is not yet disclosing the targets or ...

DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. The head biotech analyst at Goldman Sachs, Salveen Richter, made an appearance on CNBC’s “Squawk Box” on ...